Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. Gross ND, Miller DM, Khushalani NI, Divi V, et al. N Engl J Med 2022 Sep 12. doi: 10.1056/NEJMoa2209813.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gross ND, Miller DM, Khushalani NI, Divi V, et al. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. N Engl J Med 2022 Sep 12. doi: 10.1056/NEJMoa2209813.
PMID: 36094839